Analyst Laura Sutcliffe works at UBS and is focused on the Healthcare sector with 44 price targets and ratings documented since 2019 spanning on 5 stocks. Analyst's average stock valuation to be materialised ratio is 25% with an average time for price targets to be met of 57.33 days.
Most recent stock forecast was given on NVS, Novartis AG at 14-Dec-2022.
Laura Sutcliffe best performing recommendations are on GLPG (GALAPAGOS NV).
The best stock recommendation documented was for GLPG (GALAPAGOS NV) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.
Average potential price target upside
Currently, out of the existing stock ratings of Laura Sutcliffe - 4088 which are a Hold (62.59%), 2443 which are a Buy (37.41%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
44
$6.73 (18.06%)
57
1 months 1 days ago
13/30 (43.33%)
$22 (27.37%)
210
Hold
43
$5.73 (15.37%)
53
1 months 1 days ago
10/13 (76.92%)
$-4.17 (3.66%)
44
Sell
47.2
$9.93 (26.64%)
158
2 months 5 days ago
1/4 (25%)
$25.21 (15.34%)
127
Hold
52.71
$15.44 (41.43%)
68.11
3 months 23 days ago
2/6 (33.33%)
$13.58 (18.96%)
135
Hold
52
$14.73 (39.52%)
67
3 months 23 days ago
2/3 (66.67%)
$7.26 (18.40%)
45
